Focus on the gut-liver axis: Semisynthetic bile acid has anti-inflammatory effects on the gut

A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of pro-inflammatory T helper 17 cells (TH17) and at the same time promotes the generation of anti-inflammatory regulatory T cells. This could be a promising new therapeutic option for patients with TH17-mediated intestinal diseases.

Focus on the gut-liver axis: Semisynthetic bile acid has anti-inflammatory effects on the gut
A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of pro-inflammatory T helper 17 cells (TH17) and at the same time promotes the generation of anti-inflammatory regulatory T cells. This could be a promising new therapeutic option for patients with TH17-mediated intestinal diseases.